Table 2. Intestinal stem and cancer stem cell markers.
Marker | Type of crypt cell marked | Proof of stemnessa | Proof of cancer stemness | Number of cells required for tumour growthb |
---|---|---|---|---|
CD24 | All lower crypt cells | Organoid growth | Megacolonies Xenotransplant | N/A |
CD44 | Lower crypt cells except Paneth cells | Expression profile | Megacolonies Xenotransplant | 200–500c |
CD133 | All lower crypt cells | In vivo lineage tracing | Xenotransplant | 3000c, 262d |
CD166 | Intercalated crypt base cells and Paneth cells | Expression profile Immunofluorescence FACS | Xenotransplant | 1000–4000c |
Lgr5 | Intercalated crypt base cells | In vivo lineage tracing | Targeted Apc deletion | N/A |
Olfm4 | Intercalated crypt base cells | In situ hybridisation | In situ hybridisation | N/A |
Aldh1 | Isolated crypt base cells | Immunofluorescence | Xenotransplant | 25e |
Integrins | All lower 1/3 crypt cells (β1 integrin) | Colony forming assay | N/A | N/A |
Bmi1 | +4 Single supra-Paneth cell | In vivo lineage tracing | N/A | N/A |
Musashi1 | Intercalated crypt base and supra-Paneth cells | Immunohistochemistry | N/A | N/A |
Abbreviations: FACS=fluorescence-activated cell sorting; NOD/SCID=non-obese diabetic/severe combined immunodeficient.
Strongest evidence quoted.
In NOD/SCID mice.